Related Experiment Videos
BIM1 encodes a microtubule-binding protein in yeast
K Schwartz1, K Richards, D Botstein
1Department of Genetics, Stanford University School of Medicine, Stanford, California 94305, USA.
Molecular Biology of the Cell
|December 17, 1997
Summary
We identified BIM1, a yeast gene crucial for microtubule function, cell division, and survival. Its deletion causes defects, while overexpression is lethal, highlighting its critical role in yeast.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Microtubules are essential cytoskeletal components involved in cell division and intracellular transport.
- Yeast genetics provides a powerful model for understanding fundamental cellular processes, including microtubule dynamics.
Purpose of the Study:
- To characterize a novel yeast gene, BIM1, involved in microtubule regulation.
- To elucidate the function of BIM1 in yeast cell division, karyogamy, and response to microtubule-disrupting agents.
Main Methods:
- Yeast two-hybrid screening to identify BIM1 interacting proteins.
- Gene deletion and overexpression studies to assess BIM1 function.
- Green fluorescent protein (GFP) tagging for in vivo visualization of microtubules.
- Analysis of synthetic lethality interactions with other yeast mutants.
Main Results:
- BIM1 deletion leads to karyogamy defects, benomyl hypersensitivity, aberrant spindle behavior, and temperature sensitivity.
- Overexpression of BIM1 is lethal in wild-type yeast.
- BIM1 interacts with alpha-tubulin and is essential for proper spindle and microtubule organization.
- BIM1 exhibits synthetic lethality with mutations in several other genes, including bik1, num1, and bub3.
- A correlation exists between BIM1 interaction and synthetic lethality with specific TUB1 alleles.
Conclusions:
- BIM1 is a vital protein regulating yeast microtubule dynamics and cell division.
- BIM1 plays a critical role in karyogamy and cellular integrity.
- The findings suggest BIM1 is conserved, with human homologues like EB1 involved in cancer-related pathways.